PLC () investee company Pharm2Farm's (P2F) Gareth Cave talks to Proactive London about their new antiviral face mask that can kill coronavirus (COVID-19).
Cave talks through the technology behind the mask, which is says is much stronger than the standard mask being used by the masses to defend themselves against the virus.
Cave demonstrates the textile coating which incorporates nanoparticles with long-lasting virucidal properties.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Braveheart Investment Group named herein, including the promotion by the Company of Braveheart Investment Group in any Content on the Site, the...
FOR OUR FULL DISCLAIMER CLICK HERE